We postulate that mesenchymal cells induced by NOTCH1 activation, though less abundant than typical epithelial cells within a given SCLC tumor, can promote an immune-inflamed tumor microenvironment through STING pathway activation. The gene discussed is NOTCH1; the disease is small cell lung carcinoma.